Download PDF
Neonatologie Scan 2013; 02(04): 303-314
DOI: 10.1055/s-0033-1344850
Fortbildung
© Georg Thieme Verlag KG Stuttgart · New York

Praxis der Surfactanttherapie

Egbert Herting
Further Information

Publication History

Publication Date:
29 November 2013 (online)

Also available at
    Permissions and Reprints

Corrected by:

Praxis der SurfactanttherapieNeonatologie Scan 2013; 02(04): e1-e1
DOI: 10.1055/s-0034-1365162

Einleitung

Seit der Erstbeschreibung der Surfactanttherapie durch Fujiwara 1980 [1] sind mehr als 30 Jahre vergangen. Die Zulassung von Surfactantpräparaten in Deutschland Anfang der 1990er Jahre führte zu einem deutlichen Rückgang u. a. der Beatmungsanwendung, der Mortalität und der Pneumothoraxrate. Die Surfactanttherapie ist mittlerweile aus dem klinischen Alltag in der Neonatologie nicht mehr wegzudenken.

 

  • Literatur

  • 1 Fujiwara T, Chida S, Watabe Y et al. Artificial surfactant therapy in hyaline-membrane disease. The Lancet 1980; 315: 55-59
    CrossrefGoogle Scholar
  • 2 Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane. AM J Dis Child 1959; 5: 517-523
    Google Scholar
  • 3 Robillard E, Alarie Y, Dagenais-Perusse P et al. Microaerosol administration of synthetic beta-gamma-dipalmitolyl-l-alpha-lecitin in the respiratory distress syndrome: a preliminary report. Can Med Assoc J 1964; 90: 55-57
    Google Scholar
  • 4 Halliday HL. Surfactants: past, present and future. J Perinatol 2008; 28: 47-56
    CrossrefGoogle Scholar
  • 5 Ramanathan R. Choosing a right surfactant for Respiratory Distress Syndrome treatment. Neonatology 2009; 95: 1-5
    CrossrefGoogle Scholar
  • 6 Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Chochrane Database Syst Rev 2001; DC000144
    Google Scholar
  • 7 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; CD004454
    Google Scholar
  • 8 Herting E, Schiffmann H, Roth C et al. Surfactant lavage demonstrates protein fibrils in an neonate with congenital surfactant protein b deficiency. Am JRespir Crit Care Med 2002; 166: 1292-1294
    Google Scholar
  • 9 Valls-i-Soler A, López-Herida J, Fernández-Ruanova MB et al. A simplified surfactant dosing procedure in respiratory distress syndrome: the “side-hole” randomized study. Spanish Surfactant Collaborative Group. Acta Paediatr 1997; 86: 747-751
    CrossrefGoogle Scholar
  • 10 Stevens TP, Harrington EW, Blennow M et al. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilaton for preterm infants with or at risk for respiratoiry distress syndrome. Cochrane Syst Rev 2007; CD003063
    Google Scholar
  • 11 Verder H, Robertson B, Greisen G et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994; 331: 1051-1055
    CrossrefGoogle Scholar
  • 12 Bohlin K, Jonsson B, Gustafsson A-S et al. Continuous positive airway pressure and surfactant. Neonatology 2008; 93: 309-315
    CrossrefGoogle Scholar
  • 13 Kribs A, Pillekamp F, Hünseler C et al. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age ≤ 27 weeks). Paediatr Anaesth 2007; 17: 364-369
    CrossrefGoogle Scholar
  • 14 Kribs A, Härtel C, Kattner E et al. Spontaneous breathing in preterm infants with respiratory distress: first multi-center data. Klin Paediatr 2010; 222: 13-17
    Article in Thieme ConnectGoogle Scholar
  • 15 Goepel W, Kribs A, Ziegler A et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011; 378: 1627-1634
    CrossrefGoogle Scholar
  • 16 Herting E, Kribs A, Roth B et al. Intratracheal surfactant instillation using a thin diameter tube in spontaneously breathing infants – on the way to clinical practice in Germany?. Neonatology 2012; 101: 362 (Abstract)
    Google Scholar
  • 17 Kribs A, Roll C, Göpel W et al. Eine endotracheale Surfactantgabe unter CPAP-unterstützter Spontanatmung optimiert das Outcome extrem unreifer Frühgeborener – Ergebnisse der NINSAPP-Studie (Non Intubated Surfactant Application). Monatsschr Kinderheilkd 2013; 161: 1, 23 (Abstract)
    Google Scholar
  • 18 Dargaville PA. Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimal invasive techniques. Neonatology 2012; 101: 326-336
    Google Scholar
  • 19 Klebermass-Schrehof K, Wald M, Schwindt J et al. Less Invasive Surfactant Administration in Extremely Preterm Infants: Impact on Mortality and Morbidity. Neonatology 2013; 103: 252-258
    CrossrefPubMedGoogle Scholar
  • 20 Herting E, Kribs A, Roth B et al. Growth and development of VLBW-infants after less invasive surfactant administration during spontaneous breathing: two year follow-up of the AMV-trial. Neonatology 2013; 103: 349 (Abstract)
    Google Scholar
  • 21 Kanmaz HG, Erdeve O, Canpolat FE et al. Surfactant Administration via Thin Catheter During Spontaneous Breathing: Randomized Controlled Trial. Pediatrics 2013; 131: e502-e509
    CrossrefPubMedGoogle Scholar
  • 22 Dargaville PA, Aiyappan A, De Paoli AG et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal 2013; 98: F122-126
    CrossrefGoogle Scholar
  • 23 Support Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362: 1970-1979
    CrossrefGoogle Scholar
  • 24 Morley CJ, Davis PG, Doyle LW et al. COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700-708
    CrossrefPubMedGoogle Scholar
  • 25 Pillow JJ, Minocchieri S. Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology 2012; 101: 337-344
    Google Scholar
  • 26 Kattwinkel J, Robinson M, Bloom BT et al. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol 2004; 24: 360-365
    CrossrefGoogle Scholar
  • 27 Sweet DG, Carnielli V, Greisen G et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2013 update. Neonatology 2013; 103: 353-368
    CrossrefPubMedGoogle Scholar
  • 28 Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012; CD000510
    Google Scholar
  • 29 Gortner L, Herting E. Sufactanttherapie des Atemnotsyndroms Frühgeborener (RDS). AWMF-Leitlininien-Register 024/021
    Google Scholar
  • 30 Ramanathan R, Rasmussen MR, Gerstmann DR et al. A randomized multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol 2004; 21: 109-119
    Article in Thieme ConnectGoogle Scholar
  • 31 Speer CP, Robertson B, Curstedt T et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992; 89: 13-20
    Google Scholar
  • 32 Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996; 97: 48-52
    Google Scholar
  • 33 Herting E, Gefeller O, Land M et al. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics 2000; 106: 957-964
    CrossrefGoogle Scholar
  • 34 Pandit PB, Dunn MS, Kelly EN et al. Surfactant replacement in neonates with early chronic lung disease. Pediatrics 1995; 95: 851-854
    Google Scholar
  • 35 Aziz A, Ohlsson A. Surfactant for pulmonary haemorrhage in neonates. Cochrane Database Syst Rev 2012; CD005254
    Google Scholar
  • 36 Wiswell TE, Knight GR, Finer NN et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 2002; 109: 1081-1087
    CrossrefGoogle Scholar
  • 37 Herting E, Gan X, Rauprich P et al. Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia. Am J Respir Crit Care Med 1999; 159: 1862-1867
    CrossrefGoogle Scholar